| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |